Bayer Pharmaceuticals is defending its decision to pull a free anti-coagulent drug from fifteen hundred patients with blood problems.
Recent stories from Morning Report
Get the RNZ app
for easy access to all your favourite programmes
for easy access to all your favourite programmes
